PWM
ARKG icon

Purus Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Purus Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$768K Sell
18,263
-420
-2% -$13.4K 0.21% 81
2026
Q1 		$494K Sell
18,683
-178
-0.9% -$5.21K 0.16% 90
2025
Q4 		$546K Buy
18,861
+25
+0.1% +$750 0.17% 82
2025
Q3 		$523K Sell
18,836
-1,777
-9% -$44.9K 0.17% 82
2025
Q2 		$502K Sell
20,613
-125
-0.6% -$2.74K 0.17% 83
2025
Q1 		$431K Sell
20,738
-381
-2% -$9.57K 0.18% 81
2024
Q4 		$497K Sell
21,119
-65,801
-76% -$1.62M 0.2% 74
2024
Q3 		$2.23M Buy
86,920
+265
+0.3% +$6.75K 0.94% 27
2024
Q2 		$2.03M Sell
86,655
-1,070
-1% -$27K 0.9% 28
2024
Q1 		$2.52M Sell
87,725
-3,534
-4% -$106K 1.25% 21
2023
Q4 		$2.99M Sell
91,259
-5,254
-5% -$143K 1.74% 17
2023
Q3 		$2.69M Sell
96,513
-844
-0.9% -$27.6K 1.82% 16
2023
Q2 		$3.32M Buy
97,357
+1,883
+2% +$59.2K 2.15% 13
2023
Q1 		$2.87M Sell
95,474
-475
-0.5% -$14.7K 2.27% 13
2022
Q4 		$2.71M Sell
95,949
-2,473
-3% -$78.5K 2.46% 10
2022
Q3 		$3.23M Sell
98,422
-2,462
-2% -$90.4K 2.98% 9
2022
Q2 		$3.18M Sell
100,884
-1,368
-1% -$47.8K 2.84% 11
2022
Q1 		$4.7M Sell
102,252
-1,443
-1% -$68.8K 3.25% 10
2021
Q4 		$6.35M Sell
103,695
-10,617
-9% -$734K 3.98% 5
2021
Q3 		$8.54M Buy
114,312
+154
+0.1% +$12.9K 5.9% 2
2021
Q2 		$10.6M Buy
114,158
+1,443
+1% +$123K 7.6% 2
2021
Q1 		$10M Sell
112,715
-514
-0.5% -$51K 8.41% 2
2020
Q4 		$10.6M Buy
+113,229
New +$9.02M 9.42% 2

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Purus Wealth Management's ARKG Position: Q2 2026 in Review

Purus Wealth Management reduced its ARK Genomic Revolution ETF (ARKG) stake by 2.2% in Q2 2026, selling an estimated $13.4K and leaving 18,263 shares worth $768K. The position accounts for 0.21% of the portfolio, ranked #81.

Purus Wealth Management first reported a position in ARKG in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.6M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Purus Wealth Management held 18,263 shares of ARK Genomic Revolution ETF worth $768K as of Q2 2026.
  • Purus Wealth Management sold 420 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $13.4K.
  • ARK Genomic Revolution ETF made up 0.21% of Purus Wealth Management's portfolio in Q2 2026, its #81 holding.
  • Purus Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2020 and has held it in 23 quarters since.
  • Purus Wealth Management's ARK Genomic Revolution ETF position peaked at $10.6M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Purus Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.